Graphpad renewal

The Food and Drug Administration is forecasting the renewal of a contract for Graphpad software, a tool commonly used for scientific data analysis and graphing. The opportunity is listed under NAICS code 511210, indicating it relates to software publishing, and is posted as a forecast with no formal solicitation number yet issued. The agency's Center for Drug Evaluation and Research will manage the acquisition through its Cder Acquisition Liaison, who can be contacted at cderacquisitions@fda.hhs.gov; the contracting officer position is currently listed as to be determined. There is no specified place of performance or set-aside status, and no details about dollar value, term length, or specific deliverables have been provided. The forecast serves as an early indicator of the agency’s intent to renew its existing Graphpad licensing or subscription agreement, allowing vendors to prepare for a potential future solicitation.